Non-isoflavones Diet Incurred Metabolic Modifications Induced by Constipation in Rats via Targeting Gut MicrobiotaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how the absence of dietary isoflavones affects constipation-related physiology and gut microbiota composition in rats. Researchers compared rats fed a normal chow diet containing isoflavones (ISO group) against rats fed a non-isoflavone diet (NISO group), building on earlier work that had found differences in isoflavone pharmacokinetics between these two diets. The isoflavones studied were derived from Semen sojae praeparatum. The team used 16S rRNA sequencing to characterize shifts in gut bacterial populations linked to these dietary differences.
Who was studied?
The subjects were rats divided into two dietary groups: one fed a normal chow diet containing isoflavones (ISO) and one fed a non-isoflavones diet (NISO). The abstract does not specify the exact number of animals, their strain, sex, or age. Findings therefore reflect a controlled animal-model comparison rather than a human cohort.
What were the most important findings?
Rats on the non-isoflavone diet showed significantly reduced fecal pellet numbers, lower fecal water content, and slower intestinal transit rate compared to the isoflavone-fed group, all indicating worsened constipation. Serum concentrations of substance P and vasoactive intestinal peptide, both involved in gut motility signaling, were also decreased in the NISO group. Sequencing revealed that 5 phyla and 21 genera changed significantly with diet, with Firmicutes, Bacteroidetes, Blautia, Prevotella, Lactobacillus, and Bifidobacterium most closely tied to constipation status. Lactobacillus, which produces beta-glucosidase needed to convert glycosides into bioactive aglycones, was decreased in the non-isoflavone group.
What are the greatest implications of this study?
The findings suggest that dietary isoflavones help support gut motility and stool consistency partly by sustaining beneficial bacterial populations such as Lactobacillus and Bifidobacterium. Loss of these isoflavones appears to disrupt microbiota composition and motility-related signaling peptides, worsening constipation symptoms. This points to a diet-microbiota-motility axis in which isoflavone intake could be a modifiable factor in managing constipation. The abstract does not report on Desulfovibrio, sulfate-reducing bacteria, or hydrogen sulfide, so this study does not speak to sulfur metabolism pathways.